about
Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsinPediatric meningioma: current approaches and future direction.Meningiomas in children and adolescents: a meta-analysis of individual patient data.Chemotherapy increases amenability of surgical resection in congenital glioblastoma.Morbidity in survivors of child and adolescent meningiomaIncreased Body Mass Index during Therapy for Childhood Acute Lymphoblastic Leukemia: A Significant and Underestimated Complication.Rare childhood cancers--an increasing entity requiring the need for global consensus and collaboration.Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer.Hepatic sinusoidal obstruction syndrome during chemotherapy for childhood medulloblastoma: report of a case and review of the literature.The evolution of clinical trials for infant acute lymphoblastic leukemia.Childhood craniopharyngioma: 20-year institutional experience in Western Australia.Immunogenicity and safety of single-dose, 13-valent pneumococcal conjugate vaccine in pediatric and adolescent oncology patients.The Fremantle lead study part 2.Acute onset of pustules at the site of tape placement in an immunocompromised infant with acute myeloid leukemia. Diagnosis: primary cutaneous aspergillosis.Molecular characterization of identical, novel MLL-EPS15 translocation and individual genomic copy number alterations in monozygotic infant twins with acute lymphoblastic leukemia.Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.Efficacy of acute myeloid leukemia therapy without stem-cell transplantation in a child with blastic plasmacytoid dendritic cell neoplasm.Regular exercise improves the well-being of parents of children with cancer.High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for pediatric primary central nervous system lymphoma in first complete remission.Rare pattern of relapse to the pancreas and bilateral extraocular muscles in paediatric alveolar rhabdomyosarcoma.Molecular-genetic profiling and high-throughput in vitro drug screening in NUT midline carcinoma-an aggressive and fatal disease.Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology.Vaccine-preventable disease following allogeneic haematopoietic stem cell transplant in Western AustraliaEpidemiology of invasive fungal infections in immunocompromised children; an Australian national 10-year reviewTargeting the bone marrow microenvironment: a novel therapeutic strategy for pre-B acute lymphoblastic leukemiaPre-natal, clonal origin of t(1;11)(p32;q23) acute lymphoblastic leukemia in monozygotic twinsSuccessful Treatment of Congenital Erythroleukemia With Low-Dose Cytosine ArabinosideComment on: Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic reviewNew therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironmentChallenges posed by COVID-19 to children with cancerConstitutive activation of RAS/MAPK pathway cooperates with trisomy 21 and is therapeutically exploitable in Down syndrome B-cell leukemiaOptimized peripheral blood progenitor cell mobilization for autologous hematopoietic cell transplantation in children with high-risk and refractory malignanciesImmunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplantRomidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemiaRisk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemiaOutcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized StudyImmunogenicity of the inactivated influenza vaccine in children who have undergone autologous stem cell transplantInvasive fungal infections in children with acute lymphoblastic leukaemia: Results from four Australian centres, 2003-2013Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescentsA Novel Missense Mutation Affecting the N-terminal Domain of SAP Protein in X-linked Lymphoproliferative Disease
P50
Q28817780-1C9D13AB-021C-4FE3-9970-B030140C93D4Q33785024-8F241CB2-18F1-40D0-B8CB-1AC9C8CDB0D3Q34077059-0609D60D-FEEC-4B56-9CAC-51FD8FC4CEA6Q34346174-0B2ACFA9-F3CE-4CF3-B77A-B84D1E426491Q34402586-81417B5E-6376-4C69-BDB3-FDAC20B824CAQ35691561-87D483D3-3108-42AF-9D70-F337C682F94DQ35755368-70B2506C-B2D9-4F4A-9C35-99AA2116CEB8Q36528351-09202FA1-E51D-40C9-89A0-D9F0A7C6BD06Q37414178-1E0137F5-2F84-4FEC-BC07-0645C36992CEQ37730023-65BE768E-655F-44CA-8B4B-1BFA0E34AEAFQ38096461-CC7924E3-453B-455E-B404-9FBBB6BCCF12Q38684316-8CDAFF93-6E66-4EEC-BEC4-BB00DF3B5ADAQ39865836-6C5B8AC6-72F3-4D20-B2D0-C3C88B68A9CCQ41754793-06730D42-CAD2-488B-803C-03B9AFAC699BQ41890372-62B9E729-117A-46AC-BDE8-7405544B5204Q42739353-D0F61E4F-3CE0-4000-B9BC-A455C939D331Q43156053-40FF6BE1-A17F-4F19-96EC-E4076DA609E4Q47690473-8C484CE9-B0CC-4E17-A231-8D06CFC53070Q48100602-F9D06E44-70A3-47FE-B86C-78AB4E622950Q48123902-EFCD7159-53D9-426B-AEE4-052FDBC8B675Q49166169-B2BEF34E-509D-40F0-AB63-70553507731DQ53393992-09E3FA99-0CB4-4AF6-B6C2-A284BDB5CFE9Q59353253-25CD1835-C5A3-406A-B415-4F32725128C1Q61850495-4F4E5873-492A-4E2C-BB13-B3810CE2CCAFQ64064550-3F8ACD79-AB13-4AFE-8C05-11BEA3140933Q83807480-48190F03-AAA9-49AF-A7FD-0F0B67877B19Q86169930-8F74F288-48AF-4B7E-85E6-B097C191DA0FQ88307581-6F613969-8787-4B72-9D9D-6E6DB643D1E8Q88609395-0DBDB02D-9C09-49BC-8563-91BC8C271201Q90709506-78785476-6868-4981-83C2-FE7382EE5AC0Q90710875-C4D9AC6A-245E-4776-BC82-58F82F68462CQ90831490-BB72A51C-9023-4BB1-A3BC-DDB194516BDEQ90975324-50B006E7-B274-4A12-9826-2D37D3FB2BA1Q91210155-92021F0A-371A-405C-B750-2B65259BE63AQ91569787-5ADCFED8-0489-4929-A053-87579377B4C8Q91706723-E28F24E8-23BC-4D2B-B71B-2920676B6076Q91855545-3FB4E068-429C-4E9C-BC61-D093F8A7837CQ91915653-900800F2-60C4-4D51-BABC-BE67E8A2ACA7Q92206209-5CB7A391-F9F5-46C1-88BB-A8DDB4D8BAAFQ92636996-4DAACB36-F815-4CDF-85CA-C91ED463FF3A
P50
description
researcher, ORCID id # 0000-0003-1836-4075
@en
wetenschapper
@nl
name
Rishi S Kotecha
@ast
Rishi S Kotecha
@en
Rishi S Kotecha
@es
Rishi S Kotecha
@nl
type
label
Rishi S Kotecha
@ast
Rishi S Kotecha
@en
Rishi S Kotecha
@es
Rishi S Kotecha
@nl
prefLabel
Rishi S Kotecha
@ast
Rishi S Kotecha
@en
Rishi S Kotecha
@es
Rishi S Kotecha
@nl
P106
P1153
25932258900
P31
P496
0000-0003-1836-4075